Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine and Propranolol for Dental Anxiety
NCT01784250Phase 2Unknown
- Sponsor
- Universidad CES
- Start
- Aug 2012
- Primary completion
- Apr 2013
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial of Clonidine Lauriad and propranolol in Dental anxiety (3 arms), sponsored by Universidad CES. Primary endpoints: Change from baseline in Modified Dental Anxiety Scale at 4 hours and Change from baseline in Vital Signs (BP, HR, RR, O2 Saturation) at 4 hours. Status: unknown.
02
Drugs
Clonidine Lauriadpropranolol
03
Conditions
Dental anxiety
Beyond the preview
Go deeper on NCT01784250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01784250.